Precautionary measures to protect patients against the theoretical risk of contracting variant Creutzfeldt-Jakob Disease (CJD) from blood products from donors in the United Kingdom were announced last week by the Department of Health. Imported plasma will now be used while a review of plasma from donors in Britain is conducted over the next four months. The action, initiated by the Committee on Safety of Medicines, follows three recalls of …
No takes yet. Share an insight, caveat, or question.
J. Warden (1998) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: